Association between serum 25-hydroxyvitamin D and arterial stiffness in non-dialysis-dependent CKD

European Journal of Clinical Nutrition

Volumn 70, Issue 2, 2016, Pages 274-276

  Luo, Q ^a   Wang, L L ^a   Gao, Y H ^a  

^a NINGBO UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; 25-HYDROXYVITAMIN D; VITAMIN D;

ADULT; ARTERIAL STIFFNESS; ARTICLE; BODY MASS; BRACHIAL ANKLE PULSE WAVE VELOCITY; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; HOSPITAL PATIENT; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PULSE WAVE; SYSTOLIC BLOOD PRESSURE; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; AGED; ANALOGS AND DERIVATIVES; ANKLE BRACHIAL INDEX; BLOOD; CHRONIC KIDNEY FAILURE; COMPLICATION; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATHOPHYSIOLOGY; PREVALENCE; STATISTICAL MODEL;

ADULT; AGED; ANKLE BRACHIAL INDEX; FEMALE; HUMANS; LINEAR MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREVALENCE; PULSE WAVE ANALYSIS; RENAL INSUFFICIENCY, CHRONIC; VASCULAR STIFFNESS; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84956957898     PISSN: 09543007     EISSN: 14765640     Source Type: Journal    
DOI: 10.1038/ejcn.2015.146     Document Type: Article

References (26)

1. Levin A, Bakris GL, Molitch M, Smulders M, Tian J, Williams LA et al. Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease. Kidney Int 2007; 71: 31-38.
2. Chonchol M, Scragg R. 25-Hydroxyvitamin D, insulin resistance, and kidney function in the Third National Health and Nutrition Examination Survey. Kidney Int 2007; 71: 134-139.
3. Wang L, Song Y, Manson JE, Pilz S, März W, Michaëlsson K et al. Circulating 25-hydroxy-vitamin D and risk of cardiovascular disease: a meta-analysis of prospective studies. Circ Cardiovasc Qual Outcomes 2012; 5: 819-829.
4. Karras A, Haymann JP, Bozec E, Metzger M, Jacquot C, Maruani G et al. Large artery stiffening and remodeling are independently associated with all-cause mortality and cardiovascular events in chronic kidney disease. Hypertension 2012; 60: 1451-1457.
5. Kidney Disease Improving Global Outcomes. Clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl 2013; 3: 19-62.
6. Holick MF. Vitamin D deficiency. N Engl J Med 2007; 357: 266-281.
7. Forman JP, Giovannucci E, Holmes MD, Bischoff-Ferrari HA, Tworoger SS, Willett WC et al. Plasma 25-hydroxyvitamin D levels and risk of incident hypertension. Hypertension 2007; 49: 1063-1069.
8. Brøndum-Jacobsen P, Benn M, Jensen GB, Nordestgaard BG. 25-hydroxyvitamin D levels and risk of ischemic heart disease, myocardial infarction, and early death: population-based study and meta-analyses of 18. and 17. studies. Arterioscler Thromb Vasc Biol 2012; 32: 2794-2802.
9. Poole KE, Loveridge N, Barker PJ, Halsall DJ, Rose C, Reeve J et al. Reduced vitamin D in acute stroke. Stroke 2006; 37: 243-245.
10. Watson KE, Abrolat ML, Malone LL, Hoeg JM, Doherty T, Detrano R et al. Active serum vitamin D levels are inversely correlated with coronary calcification. Circulation 1997; 96: 1755-1760.
11. Zittermann A, Schleithoff SS, Tenderich G, Berthold HK, Körfer R, Stehle P. Low vitamin D status: a contributing factor in the pathogenesis of congestive heart failure? J Am Coll Cardiol 2003; 41: 105-112.
12. Shyy JY, Chien S. Role of integrins in endothelial mechanosensing of shear stress. Circ Res 2002; 91: 769-775.
13. Yamashina A, Tomiyama H, Takeda K, Tsuda H, Arai T, Hirose K et al. Validity, reproducibility, and clinical significance of noninvasive brachial-ankle pulse wave velocity measurement. Hypertens Res 2002; 25: 359-364.
14. Yoon HE, Shin DI, Kim SJ, Koh ES, Hwang HS, Chung S et al. Brachial-ankle pulse wave velocity predicts decline in renal function and cardiovascular events in early stages of chronic kidney disease. Int J Med Sci 2013; 10: 1430-1436.
15. Li YC, Kong J, Wei M, Chen ZF, Liu SQ, Cao LP. 1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system. J Clin Invest 2002; 110: 229-238.
16. O'Connell TD, Berry JE, Jarvis AK, Somerman MJ, Simpson RU. 1,25-Dihydroxyvitamin D3 regulation of cardiac myocyte proliferation and hypertrophy. Am J Physiol 1997; 272: H1751-H1758.
17. Ngai M, Lin V, Wong HC, Vathsala A, How P. Vitamin D status and its association with mineral and bone disorder in multi-ethnic chronic kidney disease population. Clin Nephrol 2014; 82: 231-239.
18. Jean G, Bresson E, Lorriaux C, Mayor B, Hurot JM, Deleaval P et al. Increased levels of serum parathyroid hormone and fibroblast growth factor-23 are the main factors associated with the progression of vascular calcification in long-hour hemodialysis patients. Nephron Clin Pract 2012; 120: 132-138.
19. Kawamoto R, Kohara K, Tabara Y, Miki T, Ohtsuka N, Kusunoki T et al. An association between decreased estimated glomerular filtration rate and arterial stiffness. Intern Med 2008; 47: 593-598.
20. Temmar M, Liabeuf S, Renard C, Czernichow S, Esper NE, Shahapuni I et al. Pulse wave velocity and vascular calcification at different stages of chronic kidney disease. J Hypertens 2010; 28: 163-169.
21. Wang MC, Tsai WC, Chen JY, Huang JJ. Stepwise increase in arterial stiffness corresponding with the stages of chronic kidney disease. Am J Kidney Dis 2005; 45: 494-501.
22. Thomas MC, Forbes JM, Cooper ME. Advanced glycation end products and diabetic nephropathy. Am J Ther 2005; 12: 562-572.
23. Mitchell GF, Dunlap ME, Warnica W, Ducharme A, Arnold JM, Tardif JC et al. Long-term trandolapril treatment is associated with reduced aortic stiffness: the prevention of events with angiotensin-converting enzyme inhibition hemodynamic substudy. Hypertension 2007; 49: 1271-1277.
24. Garg JP, Ellis R, Elliott WJ, Hasabou N, Chua D, Chertow GM et al. Angiotensin receptor blockade and arterial compliance in chronic kidney disease: a pilot study. Am J Nephrol 2005; 25: 393-399.
25. Cachofeiro V, Goicochea M, de Vinuesa SG, Oubiña P, Lahera V, Luño J. Oxidative stress and inflammation, a link between chronic kidney disease and cardiovascular disease. Kidney Int Suppl 2008; 111: S4-S9.
26. Desjardins L, Liabeuf S, Renard C, Lenglet A, Lemke HD, Choukroun G et al. FGF23 is independently associated with vascular calcification but not bone mineral density in patients at various CKD stages. Osteoporos Int 2012; 23: 2017-2025.